Marisa Peyre

Summary

Affiliation: National Institute for Biological Standards and Control
Country: UK

Publications

  1. ncbi request reprint In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation
    Marisa Peyre
    Division of Bacteriology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    Vaccine 22:2430-7. 2004
  2. ncbi request reprint Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions
    Marisa Peyre
    Division of Bacteriology, National Institute for Biological Standards and Controls, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    J Control Release 99:345-55. 2004
  3. pmc Transcutaneous immunization with cross-reacting material CRM(197) of diphtheria toxin boosts functional antibody levels in mice primed parenterally with adsorbed diphtheria toxoid vaccine
    Paul Stickings
    Division of Bacteriology, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, United Kingdom
    Infect Immun 76:1766-73. 2008
  4. ncbi request reprint An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria
    Marisa Peyre
    Division of Bacteriology, National Institute for Biological Standards and Controls, South Mimms, Potters Bar, Hertfordshire EN6 3QG, United Kingdom
    J Pharm Sci 92:957-66. 2003
  5. ncbi request reprint Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine
    Fatme Mawas
    Division of Bacteriology, National Institute for Biological Standards and Control, Hertfordshire, United Kingdom
    J Infect Dis 190:1177-82. 2004
  6. ncbi request reprint Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine
    Antonio Aguila
    Division of Immunology, Infection and Inflammation, University of Glasgow, Biomedical Research Centre, 120 University Place, Glasgow, Scotland G12 8TA, United Kingdom
    Vaccine 24:5201-10. 2006
  7. ncbi request reprint On technological and immunological benefits of multivalent single-injection microsphere vaccines
    Gerard Boehm
    Institute of Pharmaceutical Sciences, ETH Zurich, Switzerland
    Pharm Res 19:1330-6. 2002

Collaborators

Detail Information

Publications7

  1. ncbi request reprint In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation
    Marisa Peyre
    Division of Bacteriology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    Vaccine 22:2430-7. 2004
    ..To our knowledge, this is the first time the fate of immunogenic PLGA microspheres was studied in vivo following a sub-cutaneous injection route...
  2. ncbi request reprint Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions
    Marisa Peyre
    Division of Bacteriology, National Institute for Biological Standards and Controls, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    J Control Release 99:345-55. 2004
    ..These findings demonstrate the potential of microspheres as an alternative and promising strategy for combination vaccines with a further aptitude in reducing the number of inoculations required to gain functional immunity...
  3. pmc Transcutaneous immunization with cross-reacting material CRM(197) of diphtheria toxin boosts functional antibody levels in mice primed parenterally with adsorbed diphtheria toxoid vaccine
    Paul Stickings
    Division of Bacteriology, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, United Kingdom
    Infect Immun 76:1766-73. 2008
    ..These findings highlight the promising prospect of using booster administrations of CRM(197) via the transcutaneous route to establish good herd immunity against diphtheria...
  4. ncbi request reprint An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria
    Marisa Peyre
    Division of Bacteriology, National Institute for Biological Standards and Controls, South Mimms, Potters Bar, Hertfordshire EN6 3QG, United Kingdom
    J Pharm Sci 92:957-66. 2003
    ....
  5. ncbi request reprint Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine
    Fatme Mawas
    Division of Bacteriology, National Institute for Biological Standards and Control, Hertfordshire, United Kingdom
    J Infect Dis 190:1177-82. 2004
    ..However, further studies are required to confirm the potential of TCI with glycoconjugate vaccines in humans...
  6. ncbi request reprint Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine
    Antonio Aguila
    Division of Immunology, Infection and Inflammation, University of Glasgow, Biomedical Research Centre, 120 University Place, Glasgow, Scotland G12 8TA, United Kingdom
    Vaccine 24:5201-10. 2006
    ..ISCOMS based vaccines may provide a novel strategy for mucosal and systemic immunisation against diphtheria...
  7. ncbi request reprint On technological and immunological benefits of multivalent single-injection microsphere vaccines
    Gerard Boehm
    Institute of Pharmaceutical Sciences, ETH Zurich, Switzerland
    Pharm Res 19:1330-6. 2002
    ..Such vaccines are expected to improve vaccination coverage by reducing the number of vaccination sessions required to generate immunity...